Heron Therapeutics (HRTX) Profit After Tax: 2010-2025
Historic Profit After Tax for Heron Therapeutics (HRTX) over the last 13 years, with Sep 2025 value amounting to -$17.5 million.
- Heron Therapeutics' Profit After Tax fell 260.87% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.6 million, marking a year-over-year increase of 51.45%. This contributed to the annual value of -$13.6 million for FY2024, which is 87.72% up from last year.
- According to the latest figures from Q3 2025, Heron Therapeutics' Profit After Tax is -$17.5 million, which was down 634.78% from -$2.4 million recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Profit After Tax ranged from a high of $3.7 million in Q4 2024 and a low of -$63.9 million during Q1 2022.
- Moreover, its 3-year median value for Profit After Tax was -$9.2 million (2024), whereas its average is -$12.9 million.
- Within the past 5 years, the most significant YoY rise in Heron Therapeutics' Profit After Tax was 183.39% (2025), while the steepest drop was 260.87% (2025).
- Quarterly analysis of 5 years shows Heron Therapeutics' Profit After Tax stood at -$54.6 million in 2021, then soared by 63.64% to -$19.9 million in 2022, then soared by 46.03% to -$10.7 million in 2023, then skyrocketed by 134.16% to $3.7 million in 2024, then plummeted by 260.87% to -$17.5 million in 2025.
- Its Profit After Tax was -$17.5 million in Q3 2025, compared to -$2.4 million in Q2 2025 and $2.6 million in Q1 2025.